BioPharm International-10-01-2016

BioPharm International

Defining Risk Assessment of Aseptic Processes

October 02, 2016

Ask the Expert

29

10

Susan Schniepp, distinguished fellow at Regulatory Compliance Associates, discusses the assessment of risk in the processing of intravenous injectable drugs.

Calling All Authors

October 01, 2016

From the Editor

29

10

BioPharm International editors seek bioprocessing experts to contribute technical articles in 2017.

Multiparticulate technologies hot for controlled release

October 01, 2016

Cover Story

29

10

Multiparticulates are increasingly used due to their flexibility in providing controlled-release, fixed-dose combinations, ease of taste-masking, and suitability for pediatric applications

Manufacturers Face Major Changes under PDUFA VI

October 01, 2016

Regulatory Beat

29

10

Efforts to accelerate drug development will alter fee structure and require ready production sites.

BioPharm International, October 2016 Issue (PDF)

October 01, 2016

Issue PDF

29

10

Click the title above to open the BioPharm International October 2016 issue in an interactive PDF format.